Praxis Precision Medicines, Inc.

Yield per half year: +362.19%
Dividend yield: 0%
Sector: Healthcare

Praxis Precision Medicines, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
-4.81 -274.25 -98.25% -1.99 +141.38%
P/S 161.13 56.99 182.74%
P/BV 3.09 256.7 -98.79%
P/FCF -6.67 -196.64 -96.61%
Ev/Ebitda -5.83 12.51 -146.57%
Ev/S 136.1 468.02 -70.92%
Ev/FCF -8.84 -237.28 -96.28%
E/P -0.2081 0.0224 -1030.5%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-2336.1 -341.3 584.48% -6118.79 -61.82%
ROE -70.98 103.63 -168.49%
ROA -64.03 -2.84 2156.05%
ROIC -89.7 1.17 -7740.92%
ROS -2137.48 -298.77 615.43%
ROCE -44.94 3.3 -1461.93%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-0.0069 0.9675 -100.71% -0.0212 -67.71%
Nеt Debt/Ebitda 1.07 1.05 2.1%
Debt/Ratio 0.0028 0.179 -98.42%
Debt/Equity 0.0845 1.58 -94.67%
Debt/Net Income -0.0075 -1.51 -99.5%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5339 -100% 0 0%
Number of years of dividend growth 0 0.8444 -100%
DSI 0 0.2147 -100%
Average dividend growth 0 1.27 -100%
Average percentage for 5 years 0 0.5087 -100%
Average percentage for payments 0 59.63 -100%
Difference from average difference in sector -0.5339

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
484.22 -90.69 -633.93%
Growth impulse Ebitda in 5 years 222.7 -111.17 -300.32%
Growth impulse Net Income in 5 years 195.73 -103.34 -289.4%
Growth impulse FCF in 5 years 150.38 -114.74 -231.06%
Growth impulse EPS in 5 years 29.89 -98.04 -130.49%
IP Score
4.31/10

Similar companies

Alexion

Gilead Sciences

ABIOMED

Amgen

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription